Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03233555

Recruitment Status : Recruiting

First Posted : July 28, 2017

Last Update Posted : September 24, 2020

See Contacts and Locations

Sponsor:

Collaborators:

National Cancer Institute (NCI)

National Institutes of Health (NIH)

Information provided by (Responsible Party):

Rutgers, The State University of New Jersey

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	July 31, 2022
Estimated Study Completion Date :	July 31, 2022

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Davis SN, O'Malley DM, Bator A, Ohman-Strickland P, Clemow L, Ferrante JM, Crabtree BF, Miller SM, Findley P, Hudson SV. Rationale and design of extended cancer education for longer term survivors (EXCELS): a randomized control trial of 'high touch' vs. 'high tech' cancer survivorship self-management tools in primary care. BMC Cancer. 2019 Apr 11;19(1):340. doi: 10.1186/s12885-019-5531-6.

To Top